Identify Potential Liability Issues in the Early Stages of Drug Discovery In response to the growing need for early-stage in vitro toxicity testing, WuXi Biology provides a suite of toxicity assays at the cellular level. Using advanced technologies like automated patch-clamp and high content screening (HCS), these assays can be applied to your lead ID …Read More >

A Platform Supporting HBV Drug Discovery A broad assay platform for the discovery of agents for the treatment of chronic HBV infection. Services for assay establishment and validation, compound screening and profiling, and support of preclinical studies and clinical trials. Drug screening using HBV producing cell lines HBV infectious assays Reporter assays Core protein expression …Read More >